U.S., Aug. 13 -- An application to own the trademark for 'BETRUVO' has been filed on Sep. 26, 2024.
Owner(s):
Sarepta Therapeutics, Inc.; 215 First Street, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment ...